Ads
    Related paper
  1. EXPERIENCE OF MANAGEMENT OF THE PATIENT WITH THE RESYNCHRONIZATION BIVENTRICULAR PACING WITHOUT DESTRUCTION OF ATRIO-VENTRICULAR NODE SUFFERING FROM CHRONIC HEART FAILURE AND PERMANENT ATRIAL FIBRILLATION
  2. FUNCTION CLASS OF CHRONIC HEART FAILURE AND EFFICIENCY OF THERAPY AMIODARONE AND ITS COMBINATION WITH BETA-ADRENOBLOCKERS PERMANENT FORM OF ATRIAL FIBRILLATION AT PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
  3. Clinical course and risk prediction of permanent atrial fibrillation development in patients with chronic heart failure and mid-range ejection fraction of the left ventricle
  4. DIAGNOSIS AND CHOICE OF THE MANAGEMENT STRATEGY IN PATIENT WITH CARDIAC RESYNCHRONIZATION THERAPY IN CASE OF CHRONIC HEART FAILURE WITH MULTIMORBIDITY
  5. PROGNOSTIC VALUE OF NATRIURETIC PEPTIDES IN RISK ASSESSMENT OF VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION
  6. Peculiarities of pharmacotherapy of chronic heart failure with retained left ventricular efficiency and associated atrial fibrilation depending on the method of heart rhythm control
  7. PARAMETERS OF THE HEMODYNAMIC AFTER ABLATION ATRIAL FIBRILLATION AND/OR FLUTTER DEPENDING ON THE FUNCTIONAL CLASS OF CHRONIC HEART FAILURE
  8. Clinical course of chronic heart failure with preserved ejection fraction after radiofrequency catheter ablation for atrial fibrillation
  9. The level of Β-2-microglobulin, albuminuria in patients with chronic heart failure and atrial fibrillation depending on the functional state of the kidneys
  10. FUNCTIONAL CLASSES AND CLINICAL CHARACTERISTICS OF CHRONIC HEART FAILURE IN PATIENTS WITH ATRIAL FIBRILLATION AND/OR FLUTTER AFTER RADIOFREQUENCY ABLATION